To assess the effectiveness of a local Unani formulation in patients with Eczema.
Phase 2
- Conditions
- Health Condition 1: L208- Other atopic dermatitis
- Registration Number
- CTRI/2023/03/050788
- Lead Sponsor
- Central Council for Research in Unani Medicine,New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically diagnosed patients of eczema.
Mild to moderate case of eczema.
Patients who have agreed to sign the informed consent, follow the protocol and willing to participate the clinical trial voluntarily.
Exclusion Criteria
Patients below 18 and above 30 years are excluded.
Local wound and infection.
Patients with systemic diseases like cardiovascular, renal and hepatic dysfunctions.
Severe case of Dermatitis.
Pregnancy and Lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients Oriented Eczema Measure (POEM) questionnaire to be assessed at baseline and 41st day <br/ ><br>Eczema Area Severity Index (EASI) score at baseline and 41st day <br/ ><br>Photographs of lesions at baseline and 41st day.Timepoint: 40 days
- Secondary Outcome Measures
Name Time Method Itching <br/ ><br>Presence of dry skin <br/ ><br>Erythematous patches <br/ ><br>Excoriated lesions.Timepoint: 40 days